Lttl
Lttl is a telehealth platform offering compounded semaglutide and tirzepatide for weight loss, alongside microdose GLP-1 options and a separate lineup of longevity peptides, including Sermorelin, NAD+ (injectable, nasal spray, or oral), glutathione, MIC B12, L-carnitine, and methylene blue. Every plan starts with a free, two-minute online health assessment. A licensed U.S. clinician reviews the answers and builds a personalized treatment plan before any prescription is issued — Lttl is explicit that not every applicant is approved, since clinicians retain full discretion to decline treatment that isn’t medically appropriate. Lttl works with FDA-registered pharmacy partners and describes itself as LegitScript verified. The company states plainly that its compounded medications “are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.” Lttl operates without insurance billing or long-term contracts. Members can pay with FSA/HSA funds, and the company advertises “no hidden fees” and the ability to cancel a subscription at any time.